Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 14, 2012 - Issue 2
Submit an article Journal homepage
201
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Open-label evaluation of the skin-brightening efficacy of a skin-brightening system using decapeptide-12

Andrea T. KassimSkin Laser & Surgery Specialists of NY and New Jersey, USACorrespondence[email protected]
,
Mussarrat HussainSkin Laser & Surgery Specialists of NY and New Jersey, USA
&
David J. GoldbergSkin Laser & Surgery Specialists of NY and New Jersey, USA;Mount Sinai School of Medicine, New York, NY, USA
Pages 117-121 | Received 30 Nov 2011, Accepted 23 Feb 2012, Published online: 08 Mar 2012

References

  • Parvez S, Kang M, Chung HS, Cho C, Hong MC, Shin MK, Bae H. Survey and mechanism of skin depigmenting and lightening agents. Phytother Res. 2006;20:921–934.
  • Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res. 2003;16:101–110.
  • Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett. 2006;11:1–6.
  • Solano F, Briganti S, Picardo M, Ghanem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res. 2006;19(6):550–571.
  • Sadick NS, Palmisano D. Novel synthetic oligopeptide formulation offers nonirritating cosmetic alternative for the treatment of melasma. Cosmet Dermatol. 2010;23:175–179.
  • Jimenez F. How can Lumixyl complement my thriving hydroquinone-dispensing practice? Aesthetic Trends & Technologies, Special Report, February 2011.
  • Penney KB, Smith CJ, Allen JC. Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol. 1984;82:308–310.
  • Abu Ubeid A, Zhao L, Wang Y, Hantash BM. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase. J Invest Dermatol. 2009;129:2242–2249.
  • Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C, . A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011;2011: 379173.
  • Camarasa JG, Serra-Baldrich E. Exogenous ochronosis with allergic contact dermatitis from hydroquinone. Contact Dermatitis. 1994;31:57–58.
  • Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. Dermatol Clin. 2011;29:111–123.
  • Hantash BM, Jimenez F. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma. J Drugs Dermatol. 2009;8:732–735.
  • Lumixyl synthetic peptide improves hyperpigmentation. Skin Aging. 2009;17.
  • Therapeutics Update. Practical Dermatol. 2009;64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.